comparemela.com

Latest Breaking News On - Trichoscience innovations inc - Page 1 : comparemela.com

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -November 30, 2023 at 01:09 pm EST

REPLICEL LIFE SCIENCES INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the six months ended September 30, 2023 and 2022 .

United statesBritish columbiaHong kongLee bucklerDavid hallReplicel life sciences incCompany stock option planCompany or replicelInternational financial reporting standardsShiseido companyCompany optionsVenture exchangeParty transactionsBus partnershipTrichoscience innovations incInternational accounting standards board

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -October 24, 2023 at 11:14 am EDT

REPLICEL LIFE SCIENCES INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the six months ended June 30, 2023 and 2022 .

British columbiaHong kongUnited statesLee bucklerDavid hallParty transactionsBus partnershipVenture exchangeTrichoscience innovations incInternational financial reporting standardsCompany optionsShiseido companyChina health industry coReplicel life sciences incMainpointe pharmaceuticalsInternational accounting standards board

REPLICEL LIFE SCIENCES : STATEMENT OF EXECUTIVE COMPENSATION

REPLICEL LIFE SCIENCES INC. STATEMENT OF EXECUTIVE COMPENSATION Form 51-102F6V Statement of. -Today at 06:06 am- MarketScreener

Peter lewisGary boddingtonAndrew schutteDavid hallKevin mcelweeRolf hoffmanPeter lowryRolf hoffmannLee bucklerR lee bucklerSimon maBen austringCompany informationManagement company employeeTrichoscience innovations incCompany on

RepliCel Life Sciences : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the three months ended March 31, 2023 and 2022 Notice of No Auditor. | May 31, 2023

United statesHong kongBritish columbiaLee bucklerDavid hallWhile the companyMainpointe pharmaceuticalsTechnology transfer agreementGiven the companyCompany stock option planCompany or replicelInternational accounting standards boardShare of the companyReplicel life sciences incVenture exchange theVenture exchange

vimarsana © 2020. All Rights Reserved.